ENTITY

Shanghai Junshi Biosciences (688180 CH)

48

Analysis

Health Care • China

Shanghai Junshi Biosciences Co., Ltd. operates as a biopharmaceutical company. The Company develops and sells small molecule drugs, antibody drug conjugates, and other products. Shanghai Junshi Biosciences markets its products worldwide.

more

Refresh

Exchange Announcement • 07 Apr 2021 17:51

Junshi Biological H Share Announcement (君实生物H股公告)

Exchange Announcement • 28 Feb 2021 16:50

Junshi Bio Voluntarily Disclosed The Announcement On Signing An Exclusive Promotion Agreement With Astrazeneca Pharmaceuticals (君实生物自愿披露关于与阿斯利康制药签署独家推广协议的公告)

Exchange Announcement • 26 Feb 2021 16:10

Junshi Biology 2020 Annual Results Express Announcement (君实生物2020年度业绩快报公告)

Exchange Announcement • 24 Feb 2021 18:53

Junshi Biological Announcement On Voluntary Disclosure Of Pd-1/Tgf-Β Bifunctional Fusion Protein Js201 Injection To Obtain Drug Clinical Trial Application Acceptance Notice (君实生物自愿披露关于Pd-1/Tgf-Β双功能融合蛋白Js201注射液获得药物临床试验申请受理通知书的公告)

Exchange Announcement • 17 Feb 2021 16:26

Junshi Biological Voluntary Disclosure Announcement On The Fda Approval Of The Clinical Trial Application For Anti-Tigit Monoclonal Antibody Injection (君实生物自愿披露关于抗Tigit单抗注射液临床试验申请获得Fda批准的公告)

Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.44.3

x